top of page
Modern Architecture
Investing in exceptional founders with a mission to disrupt existing industries through world class technology
Who We Are

Allectus Capital Limited is an investment company with a value focused technology portfolio of listed and unlisted companies. Allectus was formed to invest in, and partner with, potentially disruptive businesses in the technology sector. Allectus oversees and supports c.US$200m in technology investments, principally in the Asia Pacific and United Kingdom, for clients of ICM Limited (ICM). Allectus is owned by QICM Ltd and UIL Limited (LSE:UTL) and managed by ICM.

We partner with and support our investment companies through regular management contact and active communication across the ICM portfolio.

We invest with the future in mind and look for deep value in our investments.

UIL logo small_edited.png

Thematic investment strategy

Technology that transforms and disrupts

Long term, high conviction and deep value

Extensive domain experience

An aligned partnership with founders

Leveraging ICM's global network

Our Principles



Deep Tech

Digital Health

AI & Automation

We look for investments that are capable of disrupting their industries and markets on a global scale.


Our thematic approach builds on significant experience investing in technology, financial services, infrastructure, utilities and resources.


We target mission driven founders and companies that have the potential for:

  • a world class product with a compelling solution, backed by proprietary ideas and intellectual property;

  • a market leading team executing a focused business plan; and

  • scaling rapidly by utilising synergies with our global network of investment professionals and portfolio companies.

We mostly invest in the sectors highlighted. We will also make a small number of high conviction investments outside of these verticals. 

Our Sectors


Series A

Series B

Select seed stage

Select late stage

Our Mandate

We invest across the capital spectrum with a Series A and Series B focus for revenue generating companies of US$1M+ ARR.


We also invest in high conviction early stage and later stage on a very selective basis, primarily where those investments would have synergistic benefit to an existing vertical (e.g fintech, health, deep tech) in partnership with the ICM Group of funds. 

Our initial cheque is normally between
US$2-10m and we will look to support portfolio companies with further investment where they have gained relevant traction and additional guidance is beneficial.

Let's get started!

bottom of page